文献速递糖尿病

代谢组学鉴定一种新型、经外部验证的妊娠期糖尿病预测检测

Metabolomic Identification of a Novel, Externally Validated Predictive Test for Gestational Diabetes Mellitus.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

基于妊娠结局预测(POP)研究12和20周孕龄母体血清代谢组学发现47种预测代谢物,其中4种在28周孕龄独立提升AUC>0.01并在Born in Bradford队列外部验证。在相同特异度下,包含年龄、BMI和4种代谢物的模型灵敏度60.2%(95%CI 52.6-67.4%),高于BMI>30 kg/m2的28.7%(95%CI 22.3-36.0%)。

要点

  • 4种代谢物(甘露糖、4-羟基谷氨酸、1,5-脱水葡萄糖醇、乳糖基-N-棕榈酰鞘氨醇(d18:1/16:0))独立预测GDM并在外部队列验证。
  • POP研究中BMI>30 kg/m2筛查GDM灵敏度28.7%(95%CI 22.3-36.0%),特异度85.4%。
  • 相同特异度下,年龄、BMI和4种代谢物模型灵敏度60.2%(95%CI 52.6-67.4%),AUC 0.82(95%CI 0.78-0.86)。

核心结论

  • 鉴定出4种对妊娠期糖尿病具有强独立预测作用的代谢物,可能在GDM筛查中具有临床实用性。

研究设计与样本

  • 在妊娠结局预测(POP)研究中对12和20周孕龄母体血清进行代谢组学分析,包括185例GDM病例和314例非病例。
  • 预测代谢物在28周孕龄POP研究血清样本中内部验证,并在Born in Bradford(BiB)队列24至28周孕龄空腹血浆中外部验证,包括349例GDM病例和2347例非病例。
  • 在POP研究中比较包含代谢物的模型与BMI>30 kg/m2的预测能力。

主要发现

  • 使用12和20周孕龄样本鉴定出47种预测代谢物。
  • 在28周孕龄,4种代谢物(甘露糖、4-羟基谷氨酸、1,5-脱水葡萄糖醇、乳糖基-N-棕榈酰鞘氨醇(d18:1/16:0))独立使Bootstrap法受试者工作特征曲线下面积(AUC)增加>0.01。
  • 4种代谢物均在BiB样本中外部验证(P=2.6×10-12、2.2×10-13、6.9×10-28、2.6×10-17)。
  • POP研究中BMI>30 kg/m2灵敏度28.7%(95%CI 22.3-36.0%),特异度85.4%;相同特异度下,使用年龄、BMI和4种代谢物的预测模型灵敏度60.2%(95%CI 52.6-67.4%),AUC 0.82(95%CI 0.78-0.86)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Undiagnosed gestational diabetes mellitus (GDM) is a major preventable cause of stillbirth. In the United Kingdom, women are selected for diagnostic testing for GDM based on risk factors, including body mass index (BMI) > 30 kg/m2. OBJECTIVE: To improve the prediction of GDM using metabolomics. METHODS: We performed metabolomics on maternal serum from the Pregnancy Outcome Prediction (POP) study at 12 and 20 weeks of gestational age (wkGA; 185 GDM cases and 314 noncases). Predictive metabolites were internally validated using the 28 wkGA POP study serum sample and externally validated using 24- to 28-wkGA fasting plasma from the Born in Bradford (BiB) cohort (349 GDM cases and 2347 noncases). The predictive ability of a model including the metabolites was compared with BMI > 30 kg/m2 in the POP study. RESULTS: Forty-seven predictive metabolites were identified using the 12- and 20-wkGA samples. At 28 wkGA, 4 of these [mannose, 4-hydroxyglutamate, 1,5-anhydroglucitol, and lactosyl-N-palmitoyl-sphingosine (d18:1/16:0)] independently increased the bootstrapped area under the receiver operating characteristic curve (AUC) by >0.01. All 4 were externally validated in the BiB samples (P = 2.6 × 10-12, 2.2 × 10-13, 6.9 × 10-28, and 2.6 × 10-17, respectively). In the POP study, BMI > 30 kg/m2 had a sensitivity of 28.7% (95% CI 22.3-36.0%) and a specificity of 85.4% whereas at the same level of specificity, a predictive model using age, BMI, and the 4 metabolites had a sensitivity of 60.2% (95% CI 52.6-67.4%) and an AUC of 0.82 (95% CI 0.78-0.86). CONCLUSIONS: We identified 4 strongly and independently predictive metabolites for GDM that could have clinical utility in screening for GDM.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sovio U, Clayton GL, Cook E, et al. Metabolomic Identification of a Novel, Externally Validated Predictive Test for Gestational Diabetes Mellitus. J Clin Endocrinol Metab. 2022. PMID: 35436338. doi:10.1210/clinem/dgac240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。